Cabergoline and Hypoacusis - a phase IV clinical study of FDA data

Summary:

Hypoacusis is reported as a side effect among people who take Cabergoline (cabergoline), especially for people who are female, 60+ old, also take Evista, and have Acromegaly.

The phase IV clinical study analyzes which people have Hypoacusis when taking Cabergoline. It is created by eHealthMe based on reports of 5,946 people who have side effects when taking Cabergoline from the FDA, and is updated regularly.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 6,257 Cabergoline users. Check the latest studies of Cabergoline.

What is Hypoacusis?

Hypoacusis (loss of hearing) is found to be associated with 1,338 drugs and 1,186 conditions by eHealthMe. Check the latest studies of Hypoacusis.

On Jul, 22, 2026

5,946 people reported to have side effects when taking Cabergoline.
Among them, 38 people (0.64%) have Hypoacusis.

Among these 38 people:

What is the gender of people who have Hypoacusis when taking Cabergoline? *

female: 75 %
male: 25 %

What is the age of people who have Hypoacusis when taking Cabergoline? *

What are other drugs people take besides Cabergoline? *

Evista: 10 people, 26.32%
Calcium: 9 people, 23.68%
Nutropin Aq: 6 people, 15.79%
Vitamin D3: 5 people, 13.16%
Fluoxetine Hydrochloride: 3 people, 7.89%
Hydrochlorothiazide: 3 people, 7.89%
Euthyrox: 3 people, 7.89%
Losartan: 3 people, 7.89%
Captopril: 3 people, 7.89%
Prednisone: 3 people, 7.89%

What are other side effects people have besides Hypoacusis? *

Memory Loss: 26 people, 68.42%
Headache (pain in head): 25 people, 65.79%
Malaise (a feeling of general discomfort or uneasiness): 25 people, 65.79%
Pain: 23 people, 60.53%
Fatigue (feeling of tiredness): 21 people, 55.26%
Abdominal Distension: 19 people, 50.00%
Dyspnea (difficult or laboured breathing): 18 people, 47.37%
Pain In Extremity: 18 people, 47.37%
Productive Cough: 18 people, 47.37%
Stress And Anxiety: 17 people, 44.74%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 29 people, 76.32%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 15 people, 39.47%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 11 people, 28.95%
Bone Atrophy (decrease in bone mass): 10 people, 26.32%
High Blood Pressure: 7 people, 18.42%
Glaucoma (increased fluid pressure in the eye with vision loss): 6 people, 15.79%
Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 6 people, 15.79%
Androgen Deficiency: 6 people, 15.79%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 6 people, 15.79%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Cabergoline and have Hypoacusis?

- Check whether Hypoacusis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cabergoline:

Cabergoline (6,257 reports)

Hypoacusis treatments and more:

Hypoacusis (48,633 reports)

Browse all side effects of Cabergoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoacusis:

Hypoacusis (1,338 drugs)

Browse all the conditions that are associated with Hypoacusis:

Hypoacusis (1,186 conditions)

Related publications that referenced our studies

Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .
Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cabergoline (the active ingredients of Cabergoline) and Cabergoline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.